tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Salveen Richter, 144 are a HOLD (33.57%), 251 are a BUY (58.51%), 34 are a SELL (7.93%).
Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 63.94% that have a potential upside of 45.79% achieved within 251 days.
Salveen Richter’s has documented 814 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on MRNA, Moderna at 15-Oct-2026.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $109 was fulfilled within 1 day with a profit of $13 (13.54%) receiving and performance score of 135.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jun-2025
$36
$16.88 (88.28%)
$37
11 days ago
(08-Oct-2026)
1/10 (10%)
$16.42 (83.86%)
173
Buy Since 15-Dec-2025
$33
$13.88 (72.59%)
$37
24 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$14.88 (77.82%)
$36
24 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 25-Sep-2025
$31
$11.88 (62.13%)
$38
24 days ago
(25-Sep-2026)
1/4 (25%)
$10.32 (49.90%)
831
Buy Since 28-Feb-2024
$35
$15.88 (83.05%)
$41
24 days ago
(25-Sep-2026)
9/15 (60%)
$14.32 (69.25%)
393
Which stock is Salveen Richter most bullish on?
Which stock is Salveen Richter most reserved on?
What Year was the first public recommendation made by Salveen Richter?
